These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21074788)

  • 21. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
    McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
    Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience.
    Xu X; Ling Q; He ZL; Gao F; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):465-70. PubMed ID: 18842490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 25. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
    Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
    Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group.
    Fagiuoli S; Leandro G; Bellati G; Gasbarrini A; Rapaccini GL; Pompili M; Rendina M; De Notariis S; Francavilla A; Gasbarrini G; Ideo G; Naccarato R
    Ital J Gastroenterol; 1996; 28(6):343-50. PubMed ID: 8891851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients.
    Singh TP; Faber C; Blume ED; Worley S; Almond CS; Smoot LB; Dillis S; Nasman C; Boyle GJ
    J Heart Lung Transplant; 2010 May; 29(5):517-22. PubMed ID: 20061164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation.
    Salizzoni M; Cavallari A; Risaliti A; Filipponi F; Gerunda GE; Forti D; Fassati LR; Cillo U; Castagneto M; Valente U; Tisone G
    Transplant Proc; 2001 May; 33(3):2258-62. PubMed ID: 11377521
    [No Abstract]   [Full Text] [Related]  

  • 30. Tacrolimus is effective in both dual and triple regimens after liver transplantation.
    Serrano J; García González M; Gómez M; Ortiz de Urbina J; López Cillero P; San Juan F; Parrilla P; Herrero JI
    Transplant Proc; 2002 Aug; 34(5):1529-30. PubMed ID: 12176469
    [No Abstract]   [Full Text] [Related]  

  • 31. Muromonab-CD3 therapy for refractory rejections after liver transplantation: a single-center experience during two decades in Japan.
    Ueda D; Hori T; Nguyen JH; Uemoto S
    J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):885-91. PubMed ID: 20458505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation across ABO blood groups.
    Lang M; Neumann UP; Steinmüller T; Neuhaus P
    Transplant Proc; 2002 Aug; 34(5):1501-2. PubMed ID: 12176457
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunosuppression withdrawal for treatment of severe infections in liver transplantation.
    Massarollo PC; Mies S; Abdala E; Leitão RM; Raia S
    Transplant Proc; 1998 Jun; 30(4):1472-4. PubMed ID: 9636598
    [No Abstract]   [Full Text] [Related]  

  • 34. Early steroid withdrawal in liver transplant patients: final report of a prospective randomized trial.
    De Carlis L; Belli LS; Rondinara GF; Alberti A; Sansalone CV; Colella G; Aseni P; Slim AO; Forti D
    Transplant Proc; 1997; 29(1-2):539-42. PubMed ID: 9123120
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection.
    Bartoletti M; Vandi G; Furii F; Bertuzzo V; Ambretti S; Tedeschi S; Pascale R; Cristini F; Campoli C; Morelli MC; Cescon M; Pinna AD; Viale P; Giannella M
    Transpl Infect Dis; 2018 Oct; 20(5):e12930. PubMed ID: 29809304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive risk assessment for early neurologic complications after liver transplantation.
    Wu SY; Chen TW; Feng AC; Fan HL; Hsieh CB; Chung KP
    World J Gastroenterol; 2016 Jun; 22(24):5548-57. PubMed ID: 27350733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus.
    Khanna A; Jain A; Ziady G; Demetris AJ; Fung JJ; Kramer D; Starzl TE
    Transplant Proc; 1997; 29(1-2):532-3. PubMed ID: 9123118
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute liver transplant rejection: incidence and the role of high-doses steroids.
    Ziolkowski J; Paczek L; Niewczas M; Senatorski G; Oldakowska-Jedynak U; Wyzgal J; Foroncewicz B; Mucha K; Zegarska J; Nyckowski P; Zieniewicz K; Patkowski W; Krawczyk M; Ziarkiewicz-Wroblewska B; Gornicka B
    Transplant Proc; 2003 Sep; 35(6):2289-91. PubMed ID: 14529918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplant program in Prague. Results of consecutive first 100 orthotopic liver transplantations.
    Ryska M; Trunecka P; Belina F; Spicak J; Peregrin J; Filip K; Vitko S
    Ann Transplant; 2000; 5(1):50-2. PubMed ID: 10850613
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuropsychiatric complications after liver transplantation: role of immunosuppression and hepatitis C.
    Tombazzi CR; Waters B; Shokouh-Amiri MH; Vera SR; Riely CA
    Dig Dis Sci; 2006 Jun; 51(6):1079-81. PubMed ID: 16865574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.